{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:10:02Z","timestamp":1783512602285,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["CFI-37589"],"award-info":[{"award-number":["CFI-37589"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113901","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:52:52Z","timestamp":1748346772000},"page":"113901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A novel cationic liposome-formulated toll like receptor (TLR) 7\/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity"],"prefix":"10.1016","volume":"384","author":[{"given":"Fatima A.","family":"Hamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyet-Minh Nguyen","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daihyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Siram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borries","family":"Demeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay T.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113901_bb0005","author":"WHO"},{"key":"10.1016\/j.jconrel.2025.113901_bb0010","author":"NIDA"},{"key":"10.1016\/j.jconrel.2025.113901_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2025.113901_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15252\/embr.201745322","article-title":"Vaccines to combat the opioid crisis: Vaccines that prevent opioids and other substances of abuse from entering the brain could effectively treat addiction and abuse","volume":"19","author":"Olson","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jconrel.2025.113901_bb0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate vaccine immunotherapy for substance use disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2025.113901_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acsptsci.1c00260","article-title":"Efficacy and selectivity of monovalent and bivalent vaccination strategies to protect against exposure to Carfentanil, Fentanyl, and their mixtures in rats","volume":"5","author":"Crouse","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jconrel.2025.113901_bb0035","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1021\/acs.jmedchem.0c01042","article-title":"Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity","volume":"63","author":"Robinson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113901_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.113901_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2018.02.006","article-title":"Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex","volume":"275","author":"Beck","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0050","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113901_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-017-0013-9","article-title":"Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant","volume":"2","author":"Torres","year":"2017","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2025.113901_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-023-00694-y","article-title":"A lipidated TLR7\/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice","volume":"8","author":"Miller","year":"2023","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2025.113901_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00697-9","article-title":"A TLR7\/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models","volume":"8","author":"Crouse","year":"2023","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2025.113901_bb0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113901_bb0075","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing efficacy and stability of an antiheroin vaccine: Examination of antinociception, opioid binding profile, and lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113901_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00329-0","article-title":"Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge","volume":"6","author":"Stone","year":"2021","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2025.113901_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.113901_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acs.jmedchem.7b01427","article-title":"A stable heroin analogue that can serve as a vaccine hapten to induce antibodies that block the effects of heroin and its metabolites in rodents and that cross-react immunologically with related drugs of abuse","volume":"61","author":"Sulima","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113901_bb0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/21645515.2018.1558697","article-title":"Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders","volume":"15","author":"Robinson","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.113901_bb0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/acs.molpharmaceut.0c00837","article-title":"Developing translational vaccines against heroin and fentanyl through investigation of adjuvants and stability","volume":"18","author":"Blake","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113901_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00247-7","article-title":"Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders","volume":"5","author":"Crouse","year":"2020","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2025.113901_bb0110","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41598-018-23777-6","article-title":"Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose","volume":"8","author":"Laudenbach","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113901_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2020.00406","article-title":"Novel lipidated Imidazoquinoline TLR7\/8 adjuvants elicit influenza-specific Th1 immune responses and protect against heterologous H3N2 influenza challenge in mice","volume":"11","author":"Miller","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2019.10.025","article-title":"Co-encapsulation of synthetic lipidated TLR4 and TLR7\/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity","volume":"315","author":"Short","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2025.113901_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the Adjuvant System story","volume":"13","author":"Gar\u00e7on","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.113901_bb0135","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0140","series-title":"Analytical Ultracentrifugation: Instrumentation, Software, and Applications","first-page":"119","article-title":"Analytical ultracentrifugation data analysis with UltraScan-III","author":"Demeler","year":"2016"},{"key":"10.1016\/j.jconrel.2025.113901_bb0145","author":"Demeler"},{"key":"10.1016\/j.jconrel.2025.113901_bb0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00249-009-0413-5","article-title":"A two-dimensional spectrum analysis for sedimentation velocity experiments of mixtures with heterogeneity in molecular weight and shape","volume":"39","author":"Brookes","year":"2010","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.jconrel.2025.113901_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.974","article-title":"Methods for the design and analysis of analytical ultracentrifugation experiments","volume":"4","author":"Demeler","year":"2024","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.jconrel.2025.113901_bb0160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.bpj.2014.02.022","article-title":"A parametrically constrained optimization method for fitting sedimentation velocity experiments","volume":"106","author":"Gorbet","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.113901_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ab.2004.08.039","article-title":"Sedimentation velocity analysis of highly heterogeneous systems","volume":"335","author":"Demeler","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2025.113901_bb0170","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/acs.bioconjchem.3c00347","article-title":"Self-adjuvanting TLR7\/8 agonist and fentanyl Hapten co-conjugate achieves enhanced protection against fentanyl challenge","volume":"34","author":"Powers","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.113901_bb0175","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113901_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(99)00037-X","article-title":"Mechanisms and kinetics of liposome-cell interactions","volume":"40","author":"D\u00fczg\u00fcne\u015f","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113901_bb0185","article-title":"Comparison of the uptake mechanisms of zwitterionic and negatively charged liposomes by HeLa cells","volume":"30","author":"Montizaan","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113901_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2025.113901_bb0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113901_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113901_bb0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0215","first-page":"1","article-title":"Liposomes as adjuvants and vaccine delivery systems","volume":"16","author":"Tretiakova","year":"2022","journal-title":"Biochem. (Mosc) Suppl. Ser. A Membr. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0220","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2011.05.061","article-title":"Vaccine adjuvant activity of 3M-052: an imidazoquinoline designed for local activity without systemic cytokine induction","volume":"29","author":"Smirnov","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113901_bb0225","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0230","article-title":"A formulated TLR7\/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines","volume":"7","author":"Hoeven","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113901_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2025.113901_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/978-1-4939-3389-1_41","article-title":"Preparation of multifunctional liposomes as a stable vaccine delivery-adjuvant system by procedure of emulsification-lyophilization","volume":"1404","author":"Wang","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0245","doi-asserted-by":"crossref","DOI":"10.1586\/erv.12.35","article-title":"Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines","volume":"11","author":"Alving","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2025.113901_bb0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2015.11.005","article-title":"Designing liposomal adjuvants for the next generation of vaccines","volume":"99","author":"Perrie","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113901_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2014.03.015","article-title":"Factors affecting alum\u2013protein interactions","volume":"466","author":"Huang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113901_bb0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2020.06.021","article-title":"Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses","volume":"326","author":"Hou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0265","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1039\/c1nr10166h","article-title":"The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses","volume":"3","author":"Ma","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.113901_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674048","article-title":"Therapeutic liposomal vaccines for dendritic cell activation or tolerance","volume":"12","author":"Nagy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0275","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00403-007-0770-9","article-title":"Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2,4-dinitrobenze in vitro","volume":"299","author":"Shi","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jconrel.2025.113901_bb0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2010.03.027","article-title":"Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response","volume":"145","author":"Henriksen-Lacey","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0285","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1021\/bi980096y","article-title":"Liposome\u2212cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes","volume":"37","author":"Miller","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2025.113901_bb0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.05.019","article-title":"The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production","volume":"154","author":"Henriksen-Lacey","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113901_bb0295","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113901_bb0300","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.2200605","article-title":"IL-4 predicts the efficacy of a candidate antioxycodone vaccine and alters vaccine-specific antibody-secreting cell proliferation in mice","volume":"210","author":"Crouse","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0305","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.2100204","article-title":"Contribution of antibody-mediated effector functions to the mechanism of efficacy of vaccines for opioid use disorders","volume":"207","author":"Kelcher","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113901_bb0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:56:06Z","timestamp":1779512166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":62,"alternative-id":["S0168365925005218"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113901","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel cationic liposome-formulated toll like receptor (TLR) 7\/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113901"}}